| 0 |
VOCAL FOLD IMMOBILITY |
13 |
0.6842 |
| 1 |
GRANULOMATOUS ROSACEA |
14 |
0.2857 |
| 2 |
BIPHASIC MESOTHELIOMA |
11 |
0.2558 |
| 3 |
ADENOVIRUS INTERSTITIAL NEPHRITIS |
14 |
0.2500 |
| 4 |
ACANTHOMA |
10 |
0.1923 |
| 5 |
ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING |
42 |
0.1772 |
| 6 |
POLYOMAVIRUS VIRAEMIA |
182 |
0.1714 |
| 7 |
PIK3CA-ACTIVATED MUTATION |
56 |
0.1687 |
| 8 |
ISOSPORIASIS |
12 |
0.1538 |
| 9 |
POLYOMAVIRUS TEST POSITIVE |
18 |
0.1525 |
| 10 |
BRAIN STEM GLIOMA |
23 |
0.1513 |
| 11 |
HEPATIC ANGIOSARCOMA |
10 |
0.1370 |
| 12 |
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY |
308 |
0.1313 |
| 13 |
VASCULAR HYALINOSIS |
11 |
0.1294 |
| 14 |
INSULINOMA |
21 |
0.1186 |
| 15 |
CARCINOID TUMOUR PULMONARY |
26 |
0.1079 |
| 16 |
CHORDOMA |
10 |
0.0971 |
| 17 |
MICROSPORIDIA INFECTION |
34 |
0.0969 |
| 18 |
CONGENITAL CORONARY ARTERY MALFORMATION |
16 |
0.0947 |
| 19 |
PLEURAL NEOPLASM |
15 |
0.0909 |
| 20 |
MYCOBACTERIUM HAEMOPHILUM INFECTION |
26 |
0.0909 |
| 21 |
VIRAEMIA |
125 |
0.0902 |
| 22 |
BK VIRUS INFECTION |
299 |
0.0886 |
| 23 |
HUMAN POLYOMAVIRUS INFECTION |
47 |
0.0885 |
| 24 |
PANCREATIC NEUROENDOCRINE TUMOUR |
55 |
0.0858 |
| 25 |
HORMONE RECEPTOR POSITIVE BREAST CANCER |
23 |
0.0846 |
| 26 |
COMPLICATIONS OF TRANSPLANTED HEART |
18 |
0.0837 |
| 27 |
CYTOMEGALOVIRUS GASTRITIS |
21 |
0.0830 |
| 28 |
BLOOD GASTRIN INCREASED |
10 |
0.0781 |
| 29 |
METASTASES TO SKIN |
74 |
0.0716 |
| 30 |
PNEUMONIA ADENOVIRAL |
14 |
0.0707 |
| 31 |
CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION |
21 |
0.0705 |
| 32 |
PSEUDOCIRRHOSIS |
22 |
0.0663 |
| 33 |
IMMUNOSUPPRESSANT DRUG LEVEL DECREASED |
77 |
0.0642 |
| 34 |
POST TRANSPLANT DISTAL LIMB SYNDROME |
13 |
0.0640 |
| 35 |
ADENOVIRAL HEPATITIS |
15 |
0.0638 |
| 36 |
BLOOD CHROMOGRANIN A INCREASED |
28 |
0.0610 |
| 37 |
PARVOVIRUS B19 INFECTION |
54 |
0.0603 |
| 38 |
PANCREATIC STEATOSIS |
16 |
0.0588 |
| 39 |
PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC |
14 |
0.0586 |
| 40 |
PARASITIC GASTROENTERITIS |
11 |
0.0573 |
| 41 |
LYMPHOCELE |
38 |
0.0572 |
| 42 |
METASTASES TO THE MEDIASTINUM |
22 |
0.0534 |
| 43 |
ENTEROCOLITIS VIRAL |
16 |
0.0526 |
| 44 |
CYTOMEGALOVIRUS GASTROENTERITIS |
11 |
0.0509 |
| 45 |
HUMAN HERPESVIRUS 8 INFECTION |
31 |
0.0509 |
| 46 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
259 |
0.0508 |
| 47 |
HERPES SIMPLEX HEPATITIS |
12 |
0.0500 |
| 48 |
GASTRIC ANTRAL VASCULAR ECTASIA |
26 |
0.0491 |
| 49 |
TRICHODYSPLASIA SPINULOSA |
18 |
0.0472 |
| 50 |
HEART TRANSPLANT REJECTION |
49 |
0.0472 |
| 51 |
LUNG TRANSPLANT REJECTION |
31 |
0.0470 |
| 52 |
METASTASES TO SOFT TISSUE |
12 |
0.0463 |
| 53 |
HEPATITIS E |
73 |
0.0462 |
| 54 |
COMPLICATIONS OF TRANSPLANTED LUNG |
14 |
0.0456 |
| 55 |
LIVER TRANSPLANT REJECTION |
80 |
0.0445 |
| 56 |
NEUROENDOCRINE TUMOUR |
63 |
0.0445 |
| 57 |
MALACOPLAKIA |
20 |
0.0437 |
| 58 |
RENAL TRANSPLANT FAILURE |
43 |
0.0435 |
| 59 |
COMPLICATIONS OF TRANSPLANTED KIDNEY |
96 |
0.0423 |
| 60 |
TRANSPLANT REJECTION |
329 |
0.0410 |
| 61 |
METASTASES TO PLEURA |
43 |
0.0410 |
| 62 |
RENAL TUBULAR ATROPHY |
36 |
0.0408 |
| 63 |
MUCOSAL TOXICITY |
11 |
0.0406 |
| 64 |
DELAYED GRAFT FUNCTION |
28 |
0.0394 |
| 65 |
METASTASES TO BREAST |
13 |
0.0392 |
| 66 |
CHRONIC ALLOGRAFT NEPHROPATHY |
30 |
0.0383 |
| 67 |
PNEUMOCYSTIS JIROVECII INFECTION |
44 |
0.0368 |
| 68 |
HORMONE RECEPTOR POSITIVE HER2 NEGATIVE BREAST CANCER |
12 |
0.0361 |
| 69 |
METASTASES TO PANCREAS |
16 |
0.0361 |
| 70 |
ANGIOSARCOMA |
16 |
0.0347 |
| 71 |
METASTASES TO HEART |
10 |
0.0331 |
| 72 |
ALVEOLAR PROTEINOSIS |
19 |
0.0321 |
| 73 |
WEST NILE VIRAL INFECTION |
24 |
0.0320 |
| 74 |
EPSTEIN-BARR VIRAEMIA |
35 |
0.0316 |
| 75 |
PNEUMONITIS CHEMICAL |
11 |
0.0315 |
| 76 |
KIDNEY FIBROSIS |
54 |
0.0311 |
| 77 |
SMOOTH MUSCLE CELL NEOPLASM |
13 |
0.0311 |
| 78 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA |
18 |
0.0305 |
| 79 |
CARBOHYDRATE ANTIGEN 15-3 INCREASED |
23 |
0.0302 |
| 80 |
CYTOMEGALOVIRUS OESOPHAGITIS |
11 |
0.0299 |
| 81 |
ENDOMETRIAL ADENOCARCINOMA |
19 |
0.0299 |
| 82 |
MEDIASTINAL DISORDER |
11 |
0.0294 |
| 83 |
METASTASES TO LIVER |
517 |
0.0294 |
| 84 |
CLEAR CELL RENAL CELL CARCINOMA |
20 |
0.0287 |
| 85 |
KIDNEY TRANSPLANT REJECTION |
137 |
0.0285 |
| 86 |
METASTASES TO LYMPH NODES |
192 |
0.0284 |
| 87 |
METASTASES TO BONE |
466 |
0.0284 |
| 88 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
93 |
0.0281 |
| 89 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
36 |
0.0273 |
| 90 |
INVASIVE LOBULAR BREAST CARCINOMA |
14 |
0.0273 |
| 91 |
ANAL ULCER |
22 |
0.0269 |
| 92 |
METASTASES TO LUNG |
309 |
0.0267 |
| 93 |
METASTASES TO SPLEEN |
11 |
0.0266 |
| 94 |
THROMBOTIC MICROANGIOPATHY |
259 |
0.0266 |
| 95 |
BREAST CANCER METASTATIC |
271 |
0.0252 |
| 96 |
METASTATIC RENAL CELL CARCINOMA |
46 |
0.0251 |
| 97 |
METASTASES TO ABDOMINAL CAVITY |
12 |
0.0244 |
| 98 |
TRANSPLANT DYSFUNCTION |
42 |
0.0235 |
| 99 |
GRAFT LOSS |
17 |
0.0234 |
| 100 |
ABDOMINAL LYMPHADENOPATHY |
20 |
0.0230 |
| 101 |
HYDROTHORAX |
19 |
0.0229 |
| 102 |
EPSTEIN-BARR VIRUS INFECTION |
143 |
0.0229 |
| 103 |
CRYPTOSPORIDIOSIS INFECTION |
12 |
0.0229 |
| 104 |
METASTASES TO PERITONEUM |
57 |
0.0225 |
| 105 |
BILE DUCT STENOSIS |
27 |
0.0225 |
| 106 |
PLEURAL DISORDER |
14 |
0.0223 |
| 107 |
CYTOMEGALOVIRUS COLITIS |
51 |
0.0222 |
| 108 |
PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED |
13 |
0.0219 |
| 109 |
LYMPHANGIOSIS CARCINOMATOSA |
22 |
0.0211 |
| 110 |
METASTASES TO SPINE |
69 |
0.0205 |
| 111 |
JC VIRUS INFECTION |
32 |
0.0200 |
| 112 |
SEROSITIS |
11 |
0.0199 |
| 113 |
CYTOMEGALOVIRUS INFECTION |
328 |
0.0197 |
| 114 |
ENCEPHALITIS VIRAL |
24 |
0.0197 |
| 115 |
BONE LESION |
70 |
0.0194 |
| 116 |
CORYNEBACTERIUM INFECTION |
10 |
0.0187 |
| 117 |
METASTASES TO PELVIS |
11 |
0.0174 |
| 118 |
HAEMOLYTIC URAEMIC SYNDROME |
40 |
0.0172 |
| 119 |
NODULAR REGENERATIVE HYPERPLASIA |
11 |
0.0171 |
| 120 |
TRANSITIONAL CELL CARCINOMA |
22 |
0.0169 |
| 121 |
PNEUMONITIS |
453 |
0.0166 |
| 122 |
PNEUMONIA CYTOMEGALOVIRAL |
32 |
0.0165 |
| 123 |
VARICELLA ZOSTER VIRUS INFECTION |
34 |
0.0164 |
| 124 |
PNEUMONIA PSEUDOMONAL |
25 |
0.0163 |
| 125 |
HEPATIC LESION |
70 |
0.0162 |
| 126 |
TUMOUR NECROSIS |
17 |
0.0161 |
| 127 |
CONCOMITANT DISEASE PROGRESSION |
31 |
0.0158 |
| 128 |
CYTOMEGALOVIRUS TEST POSITIVE |
28 |
0.0157 |
| 129 |
LYMPHADENOPATHY MEDIASTINAL |
30 |
0.0156 |
| 130 |
MALIGNANT NEOPLASM PROGRESSION |
1592 |
0.0155 |
| 131 |
CHYLOTHORAX |
11 |
0.0153 |
| 132 |
NOROVIRUS INFECTION |
22 |
0.0152 |
| 133 |
MICROANGIOPATHIC HAEMOLYTIC ANAEMIA |
12 |
0.0152 |
| 134 |
OESOPHAGITIS ULCERATIVE |
10 |
0.0146 |
| 135 |
TUMOUR MARKER INCREASED |
70 |
0.0146 |
| 136 |
ANOGENITAL WARTS |
13 |
0.0146 |
| 137 |
ADENOVIRUS INFECTION |
42 |
0.0145 |
| 138 |
PULMONARY SEPSIS |
21 |
0.0144 |
| 139 |
SQUAMOUS CELL CARCINOMA OF SKIN |
87 |
0.0144 |
| 140 |
ACTINIC KERATOSIS |
37 |
0.0142 |
| 141 |
INFECTION REACTIVATION |
16 |
0.0140 |
| 142 |
PYELONEPHRITIS ACUTE |
27 |
0.0138 |
| 143 |
TUMOUR PAIN |
18 |
0.0137 |
| 144 |
CARCINOID TUMOUR |
10 |
0.0134 |
| 145 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
59 |
0.0133 |
| 146 |
HYPERTRIGLYCERIDAEMIA |
78 |
0.0133 |
| 147 |
REFLUX GASTRITIS |
16 |
0.0133 |
| 148 |
IGA NEPHROPATHY |
22 |
0.0133 |
| 149 |
CHOLANGITIS ACUTE |
10 |
0.0132 |
| 150 |
RENAL CELL CARCINOMA |
64 |
0.0131 |
| 151 |
CHOLANGITIS |
81 |
0.0131 |
| 152 |
DIFFUSE ALVEOLAR DAMAGE |
15 |
0.0130 |
| 153 |
SINUS ARRHYTHMIA |
17 |
0.0130 |
| 154 |
METASTASES TO ADRENALS |
12 |
0.0130 |
| 155 |
ORGANISING PNEUMONIA |
64 |
0.0129 |
| 156 |
ILEAL ULCER |
13 |
0.0128 |
| 157 |
CHRONIC GRAFT VERSUS HOST DISEASE |
46 |
0.0127 |
| 158 |
ENDOCARDITIS BACTERIAL |
10 |
0.0127 |
| 159 |
STENOTROPHOMONAS INFECTION |
17 |
0.0125 |
| 160 |
LYMPHANGITIS |
10 |
0.0124 |
| 161 |
ESCHERICHIA SEPSIS |
36 |
0.0124 |
| 162 |
CYTOMEGALOVIRUS VIRAEMIA |
55 |
0.0124 |
| 163 |
RENAL TUBULAR INJURY |
15 |
0.0123 |
| 164 |
SYSTEMIC MYCOSIS |
14 |
0.0120 |
| 165 |
INVASIVE DUCTAL BREAST CARCINOMA |
32 |
0.0118 |
| 166 |
HEPATIC CANCER METASTATIC |
10 |
0.0117 |
| 167 |
PAPILLOMA VIRAL INFECTION |
19 |
0.0115 |
| 168 |
OESOPHAGEAL OBSTRUCTION |
10 |
0.0115 |
| 169 |
TONIC CONVULSION |
16 |
0.0113 |
| 170 |
PYURIA |
11 |
0.0111 |
| 171 |
COMA SCALE ABNORMAL |
32 |
0.0110 |
| 172 |
NEPHROPATHY TOXIC |
123 |
0.0109 |
| 173 |
DYSPLASIA |
13 |
0.0108 |
| 174 |
DYSLIPIDAEMIA |
55 |
0.0108 |
| 175 |
MUCOSAL INFLAMMATION |
281 |
0.0107 |
| 176 |
MALIGNANT PLEURAL EFFUSION |
18 |
0.0107 |
| 177 |
FOCAL SEGMENTAL GLOMERULOSCLEROSIS |
17 |
0.0106 |
| 178 |
CELL DEATH |
21 |
0.0106 |
| 179 |
LIVER ABSCESS |
34 |
0.0105 |
| 180 |
PROTEINURIA |
196 |
0.0103 |
| 181 |
NORMOCYTIC ANAEMIA |
15 |
0.0102 |
| 182 |
HAEMOPHILUS INFECTION |
10 |
0.0102 |
| 183 |
APHTHOUS ULCER |
79 |
0.0102 |
| 184 |
INCISIONAL HERNIA |
14 |
0.0101 |
| 185 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
101 |
0.0100 |
| 186 |
LUNG CONSOLIDATION |
28 |
0.0100 |
| 187 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
21 |
0.0099 |
| 188 |
VASCULAR STENT THROMBOSIS |
20 |
0.0098 |
| 189 |
BREAST CANCER RECURRENT |
31 |
0.0098 |
| 190 |
KLEBSIELLA SEPSIS |
11 |
0.0098 |
| 191 |
LARGE INTESTINE INFECTION |
12 |
0.0098 |
| 192 |
ENTEROCOCCAL INFECTION |
46 |
0.0095 |
| 193 |
ARTERIAL THROMBOSIS |
18 |
0.0093 |
| 194 |
RENAL TUBULAR NECROSIS |
91 |
0.0093 |
| 195 |
METASTASES TO MENINGES |
21 |
0.0092 |
| 196 |
URINARY TRACT INFECTION BACTERIAL |
23 |
0.0091 |
| 197 |
TRANSPLANT FAILURE |
22 |
0.0090 |
| 198 |
METASTASIS |
63 |
0.0088 |
| 199 |
CANCER PAIN |
22 |
0.0086 |
| 200 |
GENE MUTATION |
17 |
0.0086 |
| 201 |
HAEMATOLOGICAL INFECTION |
21 |
0.0086 |
| 202 |
BILIARY OBSTRUCTION |
11 |
0.0085 |
| 203 |
NORMOCHROMIC NORMOCYTIC ANAEMIA |
25 |
0.0083 |
| 204 |
EXPOSED BONE IN JAW |
18 |
0.0083 |
| 205 |
DISSEMINATED TUBERCULOSIS |
21 |
0.0082 |
| 206 |
DRUG LEVEL INCREASED |
135 |
0.0081 |
| 207 |
CHOLANGIOCARCINOMA |
12 |
0.0081 |
| 208 |
STRONGYLOIDIASIS |
13 |
0.0080 |
| 209 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
60 |
0.0080 |
| 210 |
KLEBSIELLA INFECTION |
40 |
0.0079 |
| 211 |
STOMATITIS |
473 |
0.0078 |
| 212 |
BRONCHOPULMONARY ASPERGILLOSIS |
60 |
0.0077 |
| 213 |
LUNG INFILTRATION |
68 |
0.0077 |
| 214 |
SOFT TISSUE INFECTION |
14 |
0.0076 |
| 215 |
HEPATITIS B REACTIVATION |
24 |
0.0076 |
| 216 |
ODYNOPHAGIA |
45 |
0.0075 |
| 217 |
HYPOPHOSPHATAEMIA |
55 |
0.0074 |
| 218 |
SKIN TOXICITY |
42 |
0.0074 |
| 219 |
CRYPTOCOCCOSIS |
12 |
0.0074 |
| 220 |
ESCHERICHIA URINARY TRACT INFECTION |
31 |
0.0073 |
| 221 |
HEPATIC MASS |
14 |
0.0073 |
| 222 |
APLASIA PURE RED CELL |
25 |
0.0073 |
| 223 |
CARCINOEMBRYONIC ANTIGEN INCREASED |
14 |
0.0072 |
| 224 |
ENTEROBACTER INFECTION |
12 |
0.0071 |
| 225 |
PSEUDOMONAS INFECTION |
61 |
0.0071 |
| 226 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
10 |
0.0071 |
| 227 |
BACTERIAL SEPSIS |
23 |
0.0071 |
| 228 |
HYPERCHOLESTEROLAEMIA |
68 |
0.0070 |
| 229 |
COVID-19 PNEUMONIA |
82 |
0.0069 |
| 230 |
PAPILLARY THYROID CANCER |
12 |
0.0069 |
| 231 |
ESCHERICHIA INFECTION |
56 |
0.0068 |
| 232 |
BILIARY DILATATION |
10 |
0.0068 |
| 233 |
SYSTEMIC CANDIDA |
17 |
0.0068 |
| 234 |
RESPIRATORY ALKALOSIS |
11 |
0.0068 |
| 235 |
LYMPHOEDEMA |
46 |
0.0066 |
| 236 |
ENCEPHALITIS |
46 |
0.0066 |
| 237 |
VENA CAVA THROMBOSIS |
11 |
0.0066 |
| 238 |
VACCINATION FAILURE |
11 |
0.0066 |
| 239 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
154 |
0.0066 |
| 240 |
OSTEONECROSIS OF JAW |
163 |
0.0066 |
| 241 |
ENTERITIS |
42 |
0.0066 |
| 242 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
185 |
0.0065 |
| 243 |
AMYLASE INCREASED |
24 |
0.0065 |
| 244 |
PORTAL HYPERTENSION |
20 |
0.0065 |
| 245 |
HEPATOCELLULAR CARCINOMA |
49 |
0.0064 |
| 246 |
CACHEXIA |
33 |
0.0064 |
| 247 |
DISEASE PROGRESSION |
758 |
0.0064 |
| 248 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
61 |
0.0064 |
| 249 |
PLEURAL EFFUSION |
388 |
0.0064 |
| 250 |
MOUTH ULCERATION |
134 |
0.0064 |
| 251 |
HUMAN HERPESVIRUS 6 INFECTION |
12 |
0.0063 |
| 252 |
DRUG LEVEL DECREASED |
64 |
0.0063 |
| 253 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
81 |
0.0063 |
| 254 |
HYDRONEPHROSIS |
47 |
0.0063 |
| 255 |
ASPERGILLUS INFECTION |
41 |
0.0062 |
| 256 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER |
11 |
0.0062 |
| 257 |
NEOPLASM PROGRESSION |
214 |
0.0061 |
| 258 |
BLOOD CREATININE ABNORMAL |
21 |
0.0061 |
| 259 |
ASCITES |
178 |
0.0060 |
| 260 |
NEUROLOGICAL DECOMPENSATION |
14 |
0.0060 |
| 261 |
METASTATIC NEOPLASM |
26 |
0.0060 |
| 262 |
PNEUMONIA KLEBSIELLA |
11 |
0.0060 |
| 263 |
BACTERIAL INFECTION |
111 |
0.0059 |
| 264 |
GRAFT VERSUS HOST DISEASE IN SKIN |
13 |
0.0059 |
| 265 |
CARDIOPULMONARY FAILURE |
23 |
0.0059 |
| 266 |
CYTOPENIA |
72 |
0.0059 |
| 267 |
LYMPHOPENIA |
83 |
0.0059 |
| 268 |
INTERSTITIAL LUNG DISEASE |
282 |
0.0058 |
| 269 |
DRUG RESISTANCE |
149 |
0.0058 |
| 270 |
HAEMATOTOXICITY |
55 |
0.0058 |
| 271 |
MENINGITIS CRYPTOCOCCAL |
10 |
0.0057 |
| 272 |
LUNG ADENOCARCINOMA |
17 |
0.0056 |
| 273 |
RECURRENT CANCER |
23 |
0.0056 |
| 274 |
REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME |
11 |
0.0056 |
| 275 |
LARGE INTESTINAL ULCER |
15 |
0.0055 |
| 276 |
PULMONARY TOXICITY |
39 |
0.0055 |
| 277 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
97 |
0.0055 |
| 278 |
DEVICE RELATED SEPSIS |
11 |
0.0055 |
| 279 |
DIFFUSE LARGE B-CELL LYMPHOMA |
42 |
0.0054 |
| 280 |
STRIDOR |
16 |
0.0054 |
| 281 |
PYELONEPHRITIS |
47 |
0.0054 |
| 282 |
GRAFT VERSUS HOST DISEASE |
39 |
0.0054 |
| 283 |
UROSEPSIS |
50 |
0.0054 |
| 284 |
RENAL IMPAIRMENT |
454 |
0.0054 |
| 285 |
RALES |
31 |
0.0053 |
| 286 |
PNEUMONIA VIRAL |
17 |
0.0053 |
| 287 |
PNEUMONIA FUNGAL |
21 |
0.0053 |
| 288 |
LUNG OPACITY |
14 |
0.0053 |
| 289 |
OESOPHAGEAL ULCER |
20 |
0.0052 |
| 290 |
APHTHOUS STOMATITIS |
12 |
0.0052 |
| 291 |
PERFORMANCE STATUS DECREASED |
24 |
0.0051 |
| 292 |
PATHOLOGICAL FRACTURE |
26 |
0.0051 |
| 293 |
NEPHROTIC SYNDROME |
35 |
0.0051 |
| 294 |
GASTROINTESTINAL TOXICITY |
24 |
0.0050 |
| 295 |
PORTAL VEIN THROMBOSIS |
16 |
0.0049 |
| 296 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
13 |
0.0049 |
| 297 |
LEUKOPENIA |
244 |
0.0049 |
| 298 |
PERICARDIAL EFFUSION |
112 |
0.0048 |
| 299 |
SHOCK HAEMORRHAGIC |
39 |
0.0048 |
| 300 |
BRAIN ABSCESS |
12 |
0.0047 |
| 301 |
HYPERGLYCAEMIA |
171 |
0.0047 |
| 302 |
SEPTIC SHOCK |
204 |
0.0047 |
| 303 |
PNEUMONIA BACTERIAL |
43 |
0.0047 |
| 304 |
HYPERURICAEMIA |
19 |
0.0046 |
| 305 |
RENAL TUBULAR DISORDER |
13 |
0.0046 |
| 306 |
DERMATITIS ACNEIFORM |
28 |
0.0046 |
| 307 |
CHOLECYSTITIS ACUTE |
26 |
0.0046 |
| 308 |
PANNICULITIS |
11 |
0.0045 |
| 309 |
HYPERLIPIDAEMIA |
54 |
0.0045 |
| 310 |
ENTEROCOLITIS |
26 |
0.0045 |
| 311 |
GLOMERULONEPHRITIS |
11 |
0.0045 |
| 312 |
THERAPY PARTIAL RESPONDER |
70 |
0.0045 |
| 313 |
CYSTITIS HAEMORRHAGIC |
18 |
0.0045 |
| 314 |
PULMONARY TUBERCULOSIS |
19 |
0.0044 |
| 315 |
CHOLECYSTITIS INFECTIVE |
12 |
0.0043 |
| 316 |
LARGE INTESTINE PERFORATION |
30 |
0.0043 |
| 317 |
HERPES SIMPLEX |
28 |
0.0043 |
| 318 |
PULMONARY MASS |
64 |
0.0043 |
| 319 |
ACUTE PULMONARY OEDEMA |
24 |
0.0043 |
| 320 |
ACUTE RESPIRATORY FAILURE |
82 |
0.0043 |
| 321 |
SQUAMOUS CELL CARCINOMA |
40 |
0.0042 |
| 322 |
FORCED EXPIRATORY VOLUME DECREASED |
12 |
0.0042 |
| 323 |
ERYSIPELAS |
21 |
0.0042 |
| 324 |
POTENTIATING DRUG INTERACTION |
14 |
0.0042 |
| 325 |
GASTROINTESTINAL STROMAL TUMOUR |
11 |
0.0041 |
| 326 |
HAEMOTHORAX |
12 |
0.0041 |
| 327 |
PARONYCHIA |
18 |
0.0041 |
| 328 |
GASTROINTESTINAL INJURY |
11 |
0.0041 |
| 329 |
VENOUS THROMBOSIS |
16 |
0.0041 |
| 330 |
BLOOD CREATININE INCREASED |
265 |
0.0041 |
| 331 |
THORACIC VERTEBRAL FRACTURE |
12 |
0.0041 |
| 332 |
BASAL CELL CARCINOMA |
63 |
0.0040 |
| 333 |
OESOPHAGEAL CANDIDIASIS |
16 |
0.0040 |
| 334 |
THYROIDITIS |
12 |
0.0040 |
| 335 |
BONE MARROW DISORDER |
12 |
0.0040 |
| 336 |
EMERGENCY CARE |
12 |
0.0040 |
| 337 |
ABDOMINAL HERNIA |
18 |
0.0039 |
| 338 |
ATELECTASIS |
38 |
0.0039 |
| 339 |
DRUG LEVEL ABOVE THERAPEUTIC |
18 |
0.0039 |
| 340 |
LIPASE INCREASED |
30 |
0.0039 |
| 341 |
ENDOCARDITIS |
20 |
0.0039 |
| 342 |
HYPERCALCAEMIA |
48 |
0.0039 |
| 343 |
DRUG TITRATION ERROR |
10 |
0.0039 |
| 344 |
THROMBOCYTOPENIA |
433 |
0.0039 |
| 345 |
SKIN NECROSIS |
20 |
0.0039 |
| 346 |
SPINAL CORD COMPRESSION |
15 |
0.0038 |
| 347 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
61 |
0.0038 |
| 348 |
WOUND DEHISCENCE |
13 |
0.0038 |
| 349 |
DUODENAL ULCER HAEMORRHAGE |
11 |
0.0038 |
| 350 |
CONGESTIVE CARDIOMYOPATHY |
16 |
0.0038 |
| 351 |
HYPOMAGNESAEMIA |
53 |
0.0038 |
| 352 |
LEFT VENTRICULAR FAILURE |
13 |
0.0038 |
| 353 |
NECROSIS |
21 |
0.0038 |
| 354 |
PULMONARY ALVEOLAR HAEMORRHAGE |
21 |
0.0037 |
| 355 |
GLOMERULAR FILTRATION RATE DECREASED |
46 |
0.0037 |
| 356 |
JAUNDICE CHOLESTATIC |
13 |
0.0037 |
| 357 |
HEPATIC NEOPLASM |
12 |
0.0037 |
| 358 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
14 |
0.0037 |
| 359 |
HEPATITIS B |
22 |
0.0036 |
| 360 |
MACULE |
10 |
0.0036 |
| 361 |
CARDIAC TAMPONADE |
17 |
0.0036 |
| 362 |
MULTIPLE-DRUG RESISTANCE |
11 |
0.0035 |
| 363 |
DRUG INTERACTION |
559 |
0.0035 |
| 364 |
PATHOGEN RESISTANCE |
32 |
0.0035 |
| 365 |
AZOTAEMIA |
14 |
0.0035 |
| 366 |
HEPATIC FIBROSIS |
12 |
0.0035 |
| 367 |
ORAL PAIN |
78 |
0.0035 |
| 368 |
ORGAN FAILURE |
14 |
0.0035 |
| 369 |
PANCYTOPENIA |
194 |
0.0035 |
| 370 |
ORTHOPNOEA |
11 |
0.0035 |
| 371 |
DYSPNOEA AT REST |
10 |
0.0034 |
| 372 |
SKIN MASS |
23 |
0.0034 |
| 373 |
ACUTE KIDNEY INJURY |
525 |
0.0034 |
| 374 |
LOOSE TOOTH |
11 |
0.0034 |
| 375 |
BLOOD TRIGLYCERIDES INCREASED |
60 |
0.0034 |
| 376 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
28 |
0.0034 |
| 377 |
HOSPICE CARE |
33 |
0.0033 |
| 378 |
NEUROTOXICITY |
58 |
0.0033 |
| 379 |
GASTROENTERITIS |
48 |
0.0033 |
| 380 |
BLOOD UREA INCREASED |
55 |
0.0033 |
| 381 |
FACIAL PARALYSIS |
28 |
0.0033 |
| 382 |
IMMUNE THROMBOCYTOPENIA |
15 |
0.0033 |
| 383 |
DUODENITIS |
10 |
0.0033 |
| 384 |
GASTROINTESTINAL INFECTION |
29 |
0.0032 |
| 385 |
PLEURISY |
19 |
0.0032 |
| 386 |
ARTERIOSCLEROSIS |
30 |
0.0032 |
| 387 |
RESPIRATORY FAILURE |
231 |
0.0032 |
| 388 |
SPINAL PAIN |
37 |
0.0032 |
| 389 |
BEHAVIOUR DISORDER |
17 |
0.0031 |
| 390 |
ANURIA |
27 |
0.0031 |
| 391 |
SECOND PRIMARY MALIGNANCY |
26 |
0.0031 |
| 392 |
FIBRIN D DIMER INCREASED |
11 |
0.0031 |
| 393 |
PNEUMOTHORAX |
49 |
0.0031 |
| 394 |
DRUG LEVEL BELOW THERAPEUTIC |
17 |
0.0031 |
| 395 |
CONCOMITANT DISEASE AGGRAVATED |
19 |
0.0031 |
| 396 |
NEUTROPENIA |
418 |
0.0031 |
| 397 |
PRODUCT USE IN UNAPPROVED INDICATION |
755 |
0.0030 |
| 398 |
TUBULOINTERSTITIAL NEPHRITIS |
57 |
0.0030 |
| 399 |
CHOLECYSTITIS |
36 |
0.0030 |
| 400 |
COMPRESSION FRACTURE |
16 |
0.0030 |
| 401 |
HEPATITIS C |
36 |
0.0030 |
| 402 |
CHOLESTASIS |
57 |
0.0030 |
| 403 |
NEOPLASM RECURRENCE |
10 |
0.0029 |
| 404 |
BLOOD CREATINE INCREASED |
13 |
0.0029 |
| 405 |
ENDOMETRIOSIS |
14 |
0.0029 |
| 406 |
POLYNEUROPATHY |
35 |
0.0029 |
| 407 |
TRANSAMINASES INCREASED |
65 |
0.0029 |
| 408 |
GUILLAIN-BARRE SYNDROME |
14 |
0.0029 |
| 409 |
ANAEMIA |
549 |
0.0029 |
| 410 |
ERYTHEMA NODOSUM |
10 |
0.0028 |
| 411 |
ACUTE GRAFT VERSUS HOST DISEASE |
13 |
0.0028 |
| 412 |
LEFT VENTRICULAR DYSFUNCTION |
19 |
0.0028 |
| 413 |
AORTIC VALVE INCOMPETENCE |
12 |
0.0028 |
| 414 |
ELECTROLYTE IMBALANCE |
32 |
0.0028 |
| 415 |
STATUS EPILEPTICUS |
31 |
0.0027 |
| 416 |
BLOOD PHOSPHORUS DECREASED |
10 |
0.0027 |
| 417 |
INTESTINAL ISCHAEMIA |
15 |
0.0027 |
| 418 |
IMPAIRED HEALING |
89 |
0.0027 |
| 419 |
SEPSIS |
302 |
0.0027 |
| 420 |
HYPOALBUMINAEMIA |
21 |
0.0027 |
| 421 |
HYPOCALCAEMIA |
51 |
0.0027 |
| 422 |
ILEUS PARALYTIC |
12 |
0.0027 |
| 423 |
MALNUTRITION |
30 |
0.0027 |
| 424 |
CANDIDA INFECTION |
45 |
0.0027 |
| 425 |
RENAL CYST |
21 |
0.0026 |
| 426 |
BONE DISORDER |
48 |
0.0026 |
| 427 |
DEHYDRATION |
351 |
0.0026 |
| 428 |
HYPERVOLAEMIA |
13 |
0.0026 |
| 429 |
HAEMOLYSIS |
20 |
0.0026 |
| 430 |
HYPOXIA |
91 |
0.0026 |
| 431 |
HYPOPHAGIA |
66 |
0.0026 |
| 432 |
HEPATIC ENCEPHALOPATHY |
24 |
0.0026 |
| 433 |
CORONAVIRUS INFECTION |
17 |
0.0026 |
| 434 |
THERAPY NON-RESPONDER |
115 |
0.0026 |
| 435 |
HYPOKALAEMIA |
118 |
0.0026 |
| 436 |
CARDIAC FAILURE ACUTE |
17 |
0.0025 |
| 437 |
POSTOPERATIVE WOUND INFECTION |
17 |
0.0025 |
| 438 |
GENERALISED OEDEMA |
31 |
0.0025 |
| 439 |
BLOOD URIC ACID INCREASED |
14 |
0.0024 |
| 440 |
THERAPY INTERRUPTED |
173 |
0.0024 |
| 441 |
AORTIC DISSECTION |
10 |
0.0024 |
| 442 |
EMBOLISM |
20 |
0.0024 |
| 443 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
12 |
0.0024 |
| 444 |
METABOLIC ACIDOSIS |
77 |
0.0024 |
| 445 |
GENERAL PHYSICAL HEALTH DETERIORATION |
277 |
0.0024 |
| 446 |
LOW BIRTH WEIGHT BABY |
19 |
0.0024 |
| 447 |
CORONARY ARTERY STENOSIS |
12 |
0.0024 |
| 448 |
HYDROCEPHALUS |
13 |
0.0024 |
| 449 |
IMMUNOSUPPRESSION |
21 |
0.0024 |
| 450 |
LOCALISED OEDEMA |
11 |
0.0024 |
| 451 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
12 |
0.0024 |
| 452 |
PERITONITIS |
49 |
0.0024 |
| 453 |
ACIDOSIS |
18 |
0.0024 |
| 454 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
52 |
0.0023 |
| 455 |
HEPATIC PAIN |
10 |
0.0023 |
| 456 |
THERAPY CHANGE |
23 |
0.0023 |
| 457 |
ECCHYMOSIS |
16 |
0.0023 |
| 458 |
SKIN LESION |
64 |
0.0023 |
| 459 |
MYOPATHY |
20 |
0.0023 |
| 460 |
HYPERTRANSAMINASAEMIA |
16 |
0.0023 |
| 461 |
BRAIN OEDEMA |
29 |
0.0023 |
| 462 |
COAGULOPATHY |
38 |
0.0023 |
| 463 |
BACTERAEMIA |
27 |
0.0023 |
| 464 |
ATAXIA |
27 |
0.0023 |
| 465 |
PAPULE |
16 |
0.0023 |
| 466 |
ABDOMINAL ABSCESS |
10 |
0.0023 |
| 467 |
BREAST CANCER |
210 |
0.0023 |
| 468 |
CARDIOMYOPATHY |
33 |
0.0022 |
| 469 |
IRON DEFICIENCY |
10 |
0.0022 |
| 470 |
TOXICITY TO VARIOUS AGENTS |
374 |
0.0022 |
| 471 |
MYELODYSPLASTIC SYNDROME |
32 |
0.0022 |
| 472 |
PROTEIN URINE PRESENT |
11 |
0.0022 |
| 473 |
BLOOD MAGNESIUM DECREASED |
19 |
0.0022 |
| 474 |
WOUND INFECTION |
24 |
0.0022 |
| 475 |
HYPERKERATOSIS |
12 |
0.0022 |
| 476 |
C-REACTIVE PROTEIN INCREASED |
79 |
0.0022 |
| 477 |
BONE MARROW FAILURE |
44 |
0.0022 |
| 478 |
COLITIS |
82 |
0.0022 |
| 479 |
BLOOD PRESSURE SYSTOLIC INCREASED |
42 |
0.0022 |
| 480 |
LYMPHOCYTE COUNT DECREASED |
38 |
0.0021 |
| 481 |
PHLEBITIS |
11 |
0.0021 |
| 482 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
13 |
0.0021 |
| 483 |
LUNG INFECTION |
33 |
0.0021 |
| 484 |
SMALL INTESTINAL OBSTRUCTION |
26 |
0.0021 |
| 485 |
HAEMODYNAMIC INSTABILITY |
16 |
0.0021 |
| 486 |
LIVER FUNCTION TEST ABNORMAL |
61 |
0.0021 |
| 487 |
OLIGURIA |
13 |
0.0021 |
| 488 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
52 |
0.0021 |
| 489 |
CARDIAC FAILURE |
168 |
0.0021 |
| 490 |
LUNG DISORDER |
102 |
0.0021 |
| 491 |
DECREASED APPETITE |
483 |
0.0021 |
| 492 |
DYSPNOEA EXERTIONAL |
78 |
0.0021 |
| 493 |
MUSCULOSKELETAL CHEST PAIN |
32 |
0.0021 |
| 494 |
METABOLIC DISORDER |
12 |
0.0021 |
| 495 |
HEPATIC FUNCTION ABNORMAL |
77 |
0.0021 |
| 496 |
URINE OUTPUT DECREASED |
18 |
0.0021 |
| 497 |
BLOOD CALCIUM INCREASED |
18 |
0.0021 |
| 498 |
HYPOVOLAEMIA |
12 |
0.0020 |
| 499 |
ACUTE HEPATIC FAILURE |
28 |
0.0020 |
| 500 |
OEDEMA |
111 |
0.0020 |
| 501 |
OEDEMA PERIPHERAL |
249 |
0.0020 |
| 502 |
NEPHROPATHY |
19 |
0.0020 |
| 503 |
RESPIRATORY TRACT INFECTION |
53 |
0.0020 |
| 504 |
LIVER DISORDER |
90 |
0.0020 |
| 505 |
HEPATIC FAILURE |
61 |
0.0020 |
| 506 |
TASTE DISORDER |
41 |
0.0020 |
| 507 |
HYPOGLYCAEMIA |
98 |
0.0020 |
| 508 |
BLOOD SODIUM DECREASED |
38 |
0.0020 |
| 509 |
HYPERNATRAEMIA |
10 |
0.0020 |
| 510 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
110 |
0.0020 |
| 511 |
ACUTE MYELOID LEUKAEMIA |
31 |
0.0020 |
| 512 |
RENAL FAILURE |
264 |
0.0020 |
| 513 |
DUODENAL ULCER |
14 |
0.0020 |
| 514 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
33 |
0.0020 |
| 515 |
FISTULA |
22 |
0.0020 |
| 516 |
HAEMATURIA |
67 |
0.0020 |
| 517 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
17 |
0.0020 |
| 518 |
CARDIOMEGALY |
24 |
0.0019 |
| 519 |
SKIN CANCER |
42 |
0.0019 |
| 520 |
DEVICE RELATED INFECTION |
30 |
0.0019 |
| 521 |
HEMIPARESIS |
33 |
0.0019 |
| 522 |
ORAL HERPES |
38 |
0.0019 |
| 523 |
FEBRILE NEUTROPENIA |
129 |
0.0019 |
| 524 |
DIARRHOEA |
1255 |
0.0019 |
| 525 |
SKIN ULCER |
50 |
0.0019 |
| 526 |
FLANK PAIN |
18 |
0.0019 |
| 527 |
ASPIRATION |
21 |
0.0019 |
| 528 |
APLASTIC ANAEMIA |
10 |
0.0019 |
| 529 |
NEOPLASM |
22 |
0.0019 |
| 530 |
TACHYPNOEA |
26 |
0.0019 |
| 531 |
ORAL CANDIDIASIS |
25 |
0.0019 |
| 532 |
GINGIVAL PAIN |
15 |
0.0019 |
| 533 |
RESPIRATORY DISTRESS |
52 |
0.0019 |
| 534 |
PNEUMONIA |
609 |
0.0019 |
| 535 |
EJECTION FRACTION DECREASED |
29 |
0.0019 |
| 536 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
11 |
0.0019 |
| 537 |
ANAL ABSCESS |
10 |
0.0019 |
| 538 |
BREAST CANCER STAGE III |
12 |
0.0019 |
| 539 |
PYREXIA |
640 |
0.0018 |
| 540 |
POLYURIA |
15 |
0.0018 |
| 541 |
EATING DISORDER |
39 |
0.0018 |
| 542 |
HYPONATRAEMIA |
103 |
0.0018 |
| 543 |
BONE PAIN |
107 |
0.0018 |
| 544 |
TYPE 1 DIABETES MELLITUS |
11 |
0.0018 |
| 545 |
APPENDICITIS |
17 |
0.0018 |
| 546 |
HYPOTHYROIDISM |
58 |
0.0018 |
| 547 |
SPINAL COMPRESSION FRACTURE |
15 |
0.0018 |
| 548 |
FOLLICULITIS |
19 |
0.0018 |
| 549 |
DIABETES MELLITUS |
138 |
0.0018 |
| 550 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
16 |
0.0018 |
| 551 |
ANGIOEDEMA |
80 |
0.0018 |
| 552 |
MYELOSUPPRESSION |
65 |
0.0018 |
| 553 |
MULTI-ORGAN FAILURE |
31 |
0.0018 |
| 554 |
HAEMOPTYSIS |
50 |
0.0018 |
| 555 |
ENCEPHALOPATHY |
44 |
0.0018 |
| 556 |
HAEMOLYTIC ANAEMIA |
16 |
0.0018 |
| 557 |
INTESTINAL PERFORATION |
20 |
0.0018 |
| 558 |
ILEUS |
22 |
0.0018 |
| 559 |
GENERAL PHYSICAL CONDITION ABNORMAL |
12 |
0.0018 |
| 560 |
MITRAL VALVE INCOMPETENCE |
20 |
0.0018 |
| 561 |
PULMONARY OEDEMA |
79 |
0.0018 |
| 562 |
TRICUSPID VALVE INCOMPETENCE |
14 |
0.0018 |
| 563 |
MYOCLONUS |
21 |
0.0018 |
| 564 |
DRUG INTOLERANCE |
169 |
0.0017 |
| 565 |
PULMONARY EMBOLISM |
166 |
0.0017 |
| 566 |
CHOLELITHIASIS |
57 |
0.0017 |
| 567 |
PANCREATITIS ACUTE |
39 |
0.0017 |
| 568 |
RENAL FAILURE ACUTE |
73 |
0.0017 |
| 569 |
HEPATITIS |
44 |
0.0017 |
| 570 |
HAEMOGLOBIN ABNORMAL |
11 |
0.0017 |
| 571 |
HEPATOTOXICITY |
38 |
0.0017 |
| 572 |
HYPERTHERMIA |
13 |
0.0017 |
| 573 |
EPILEPSY |
52 |
0.0017 |
| 574 |
URINARY TRACT INFECTION |
290 |
0.0017 |
| 575 |
CLOSTRIDIUM DIFFICILE COLITIS |
18 |
0.0017 |
| 576 |
DIVERTICULUM |
12 |
0.0017 |
| 577 |
JAUNDICE |
45 |
0.0017 |
| 578 |
BLOOD POTASSIUM INCREASED |
27 |
0.0017 |
| 579 |
HYPERTENSION |
352 |
0.0017 |
| 580 |
ALANINE AMINOTRANSFERASE INCREASED |
102 |
0.0017 |
| 581 |
HAEMATOMA |
43 |
0.0017 |
| 582 |
ASPARTATE AMINOTRANSFERASE INCREASED |
88 |
0.0017 |
| 583 |
HELICOBACTER INFECTION |
17 |
0.0017 |
| 584 |
ADRENAL INSUFFICIENCY |
20 |
0.0016 |
| 585 |
OESOPHAGITIS |
18 |
0.0016 |
| 586 |
HEPATIC CYTOLYSIS |
21 |
0.0016 |
| 587 |
TREATMENT FAILURE |
134 |
0.0016 |
| 588 |
SUDDEN DEATH |
17 |
0.0016 |
| 589 |
SKIN INFECTION |
18 |
0.0016 |
| 590 |
HEPATIC CIRRHOSIS |
30 |
0.0016 |
| 591 |
SARS-COV-2 TEST POSITIVE |
21 |
0.0016 |
| 592 |
HAEMOGLOBIN DECREASED |
163 |
0.0016 |
| 593 |
EPISTAXIS |
118 |
0.0016 |
| 594 |
OFF LABEL USE |
1375 |
0.0016 |
| 595 |
DISSEMINATED INTRAVASCULAR COAGULATION |
22 |
0.0016 |
| 596 |
NEUTROPHIL COUNT INCREASED |
16 |
0.0016 |
| 597 |
INFECTION |
226 |
0.0016 |
| 598 |
COVID-19 |
273 |
0.0016 |
| 599 |
LEUKOCYTOSIS |
28 |
0.0015 |
| 600 |
HYPERBILIRUBINAEMIA |
16 |
0.0015 |
| 601 |
HEPATITIS ACUTE |
10 |
0.0015 |
| 602 |
SPLENOMEGALY |
18 |
0.0015 |
| 603 |
PULMONARY HAEMORRHAGE |
12 |
0.0015 |
| 604 |
BRAIN NEOPLASM |
14 |
0.0015 |
| 605 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
14 |
0.0015 |
| 606 |
FURUNCLE |
12 |
0.0015 |
| 607 |
CHRONIC KIDNEY DISEASE |
115 |
0.0015 |
| 608 |
ISCHAEMIC STROKE |
27 |
0.0015 |
| 609 |
BLOOD CALCIUM DECREASED |
17 |
0.0015 |
| 610 |
LYMPHADENOPATHY |
53 |
0.0015 |
| 611 |
CHOLECYSTITIS CHRONIC |
10 |
0.0015 |
| 612 |
BLOOD PRESSURE DIASTOLIC DECREASED |
11 |
0.0015 |
| 613 |
STAPHYLOCOCCAL INFECTION |
49 |
0.0015 |
| 614 |
DERMATITIS |
31 |
0.0015 |
| 615 |
ABNORMAL LOSS OF WEIGHT |
10 |
0.0015 |
| 616 |
CLOSTRIDIUM DIFFICILE INFECTION |
32 |
0.0015 |
| 617 |
WEIGHT DECREASED |
409 |
0.0015 |
| 618 |
SUPRAVENTRICULAR TACHYCARDIA |
14 |
0.0015 |
| 619 |
BLOOD GLUCOSE ABNORMAL |
27 |
0.0015 |
| 620 |
PULMONARY FIBROSIS |
28 |
0.0015 |
| 621 |
SEIZURE |
167 |
0.0014 |
| 622 |
LARGE INTESTINE POLYP |
10 |
0.0014 |
| 623 |
HYPERTENSIVE CRISIS |
16 |
0.0014 |
| 624 |
INFLAMMATORY BOWEL DISEASE |
14 |
0.0014 |
| 625 |
HEPATOMEGALY |
14 |
0.0014 |
| 626 |
THERAPY CESSATION |
73 |
0.0014 |
| 627 |
MALIGNANT MELANOMA |
19 |
0.0014 |
| 628 |
RENAL PAIN |
15 |
0.0014 |
| 629 |
DRUG-INDUCED LIVER INJURY |
44 |
0.0014 |
| 630 |
HEPATIC STEATOSIS |
26 |
0.0014 |
| 631 |
SHOCK |
32 |
0.0014 |
| 632 |
ELECTROCARDIOGRAM QT PROLONGED |
50 |
0.0014 |
| 633 |
BLOOD PRESSURE INCREASED |
212 |
0.0014 |
| 634 |
CENTRAL NERVOUS SYSTEM LESION |
19 |
0.0014 |
| 635 |
VIRAL INFECTION |
46 |
0.0014 |
| 636 |
NODULE |
18 |
0.0014 |
| 637 |
EYELID OEDEMA |
16 |
0.0014 |
| 638 |
MOTOR DYSFUNCTION |
14 |
0.0014 |
| 639 |
RENAL DISORDER |
64 |
0.0014 |
| 640 |
BLOOD CHOLESTEROL INCREASED |
64 |
0.0014 |
| 641 |
NAIL DISORDER |
12 |
0.0014 |
| 642 |
MENTAL STATUS CHANGES |
38 |
0.0014 |
| 643 |
RHABDOMYOLYSIS |
57 |
0.0014 |
| 644 |
DISEASE RECURRENCE |
65 |
0.0014 |
| 645 |
MELAENA |
30 |
0.0014 |
| 646 |
COUGH |
381 |
0.0014 |
| 647 |
BLOOD PRESSURE ABNORMAL |
27 |
0.0014 |
| 648 |
ABDOMINAL PAIN |
313 |
0.0013 |
| 649 |
PLATELET COUNT DECREASED |
143 |
0.0013 |
| 650 |
PRODUCTIVE COUGH |
64 |
0.0013 |
| 651 |
NEOPLASM MALIGNANT |
89 |
0.0013 |
| 652 |
GASTRITIS |
35 |
0.0013 |
| 653 |
ACUTE MYOCARDIAL INFARCTION |
39 |
0.0013 |
| 654 |
HEMIPLEGIA |
11 |
0.0013 |
| 655 |
ABSCESS |
21 |
0.0013 |
| 656 |
END STAGE RENAL DISEASE |
24 |
0.0013 |
| 657 |
HYPERKALAEMIA |
46 |
0.0013 |
| 658 |
VOMITING |
615 |
0.0013 |
| 659 |
SKIN PLAQUE |
11 |
0.0013 |
| 660 |
GLOSSODYNIA |
29 |
0.0013 |
| 661 |
AGRANULOCYTOSIS |
24 |
0.0013 |
| 662 |
SUBARACHNOID HAEMORRHAGE |
13 |
0.0013 |
| 663 |
INTESTINAL OBSTRUCTION |
48 |
0.0013 |
| 664 |
LEUKAEMIA |
12 |
0.0013 |
| 665 |
OSTEOMYELITIS |
23 |
0.0013 |
| 666 |
GENERALISED TONIC-CLONIC SEIZURE |
21 |
0.0013 |
| 667 |
CEREBRAL INFARCTION |
31 |
0.0013 |
| 668 |
BLOOD ALBUMIN DECREASED |
10 |
0.0013 |
| 669 |
ASTHENIA |
468 |
0.0012 |
| 670 |
REBOUND EFFECT |
14 |
0.0012 |
| 671 |
FLUID OVERLOAD |
18 |
0.0012 |
| 672 |
CELLULITIS |
62 |
0.0012 |
| 673 |
GOUT |
22 |
0.0012 |
| 674 |
HAEMATEMESIS |
31 |
0.0012 |
| 675 |
GASTRIC ULCER |
23 |
0.0012 |
| 676 |
DIABETIC KETOACIDOSIS |
29 |
0.0012 |
| 677 |
DEEP VEIN THROMBOSIS |
78 |
0.0012 |
| 678 |
OSTEOPENIA |
18 |
0.0012 |
| 679 |
HERPES ZOSTER |
68 |
0.0012 |
| 680 |
HEPATIC ENZYME INCREASED |
80 |
0.0012 |
| 681 |
DYSPNOEA |
664 |
0.0012 |
| 682 |
RESPIRATORY DISORDER |
35 |
0.0012 |
| 683 |
TENDERNESS |
12 |
0.0012 |
| 684 |
UPPER RESPIRATORY TRACT INFECTION |
53 |
0.0011 |
| 685 |
EOSINOPHILIA |
20 |
0.0011 |
| 686 |
ULCER |
18 |
0.0011 |
| 687 |
PAIN IN JAW |
32 |
0.0011 |
| 688 |
BODY TEMPERATURE DECREASED |
11 |
0.0011 |
| 689 |
CIRCULATORY COLLAPSE |
19 |
0.0011 |
| 690 |
BLOOD BILIRUBIN INCREASED |
30 |
0.0011 |
| 691 |
FATIGUE |
863 |
0.0011 |
| 692 |
NEUROPATHY PERIPHERAL |
104 |
0.0011 |
| 693 |
AMENORRHOEA |
19 |
0.0011 |
| 694 |
NEUTROPHIL COUNT DECREASED |
44 |
0.0011 |
| 695 |
RASH MACULO-PAPULAR |
24 |
0.0011 |
| 696 |
GASTROINTESTINAL HAEMORRHAGE |
90 |
0.0011 |
| 697 |
DIABETES MELLITUS INADEQUATE CONTROL |
19 |
0.0011 |
| 698 |
DIARRHOEA HAEMORRHAGIC |
10 |
0.0011 |
| 699 |
CORONARY ARTERY DISEASE |
32 |
0.0011 |
| 700 |
PRODUCT PRESCRIBING ISSUE |
23 |
0.0011 |
| 701 |
GASTROENTERITIS VIRAL |
19 |
0.0011 |
| 702 |
RED BLOOD CELL COUNT DECREASED |
30 |
0.0010 |
| 703 |
PELVIC PAIN |
19 |
0.0010 |
| 704 |
LETHARGY |
60 |
0.0010 |
| 705 |
THERAPEUTIC RESPONSE DECREASED |
62 |
0.0010 |
| 706 |
HAEMATOCRIT DECREASED |
20 |
0.0010 |
| 707 |
PREMATURE DELIVERY |
16 |
0.0010 |
| 708 |
FUNGAL INFECTION |
33 |
0.0010 |
| 709 |
NAUSEA |
782 |
0.0010 |
| 710 |
ABDOMINAL DISTENSION |
103 |
0.0010 |
| 711 |
FEEDING DISORDER |
20 |
0.0010 |
| 712 |
DELIRIUM |
34 |
0.0010 |
| 713 |
HYPERTHYROIDISM |
14 |
0.0010 |
| 714 |
MYOCARDIAL ISCHAEMIA |
11 |
0.0010 |
| 715 |
DRY MOUTH |
78 |
0.0010 |
| 716 |
SKIN DISORDER |
32 |
0.0010 |
| 717 |
GASTRIC HAEMORRHAGE |
11 |
0.0010 |
| 718 |
PANCREATITIS |
50 |
0.0009 |
| 719 |
TOOTH DISORDER |
21 |
0.0009 |
| 720 |
IMMUNODEFICIENCY |
14 |
0.0009 |
| 721 |
ABDOMINAL PAIN UPPER |
191 |
0.0009 |
| 722 |
PNEUMONIA ASPIRATION |
23 |
0.0009 |
| 723 |
MEDICATION ERROR |
51 |
0.0009 |
| 724 |
SINUS TACHYCARDIA |
13 |
0.0009 |
| 725 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
65 |
0.0009 |
| 726 |
CYSTITIS |
29 |
0.0009 |
| 727 |
ACNE |
69 |
0.0009 |
| 728 |
GASTROINTESTINAL PAIN |
10 |
0.0009 |
| 729 |
CARDIOGENIC SHOCK |
13 |
0.0009 |
| 730 |
BLOOD POTASSIUM DECREASED |
27 |
0.0009 |
| 731 |
DYSURIA |
33 |
0.0009 |
| 732 |
THROMBOSIS |
72 |
0.0009 |
| 733 |
DEATH |
766 |
0.0009 |
| 734 |
HOSPITALISATION |
136 |
0.0009 |
| 735 |
HYPOTENSION |
177 |
0.0009 |
| 736 |
IMPAIRED GASTRIC EMPTYING |
12 |
0.0009 |
| 737 |
DYSPHONIA |
51 |
0.0009 |
| 738 |
GASTROINTESTINAL DISORDER |
78 |
0.0009 |
| 739 |
RASH |
379 |
0.0009 |
| 740 |
PREMATURE BABY |
26 |
0.0009 |
| 741 |
CONJUNCTIVITIS |
16 |
0.0009 |
| 742 |
CHILLS |
101 |
0.0009 |
| 743 |
MUSCULOSKELETAL PAIN |
45 |
0.0009 |
| 744 |
FLATULENCE |
48 |
0.0008 |
| 745 |
BACK PAIN |
196 |
0.0008 |
| 746 |
THYROID DISORDER |
13 |
0.0008 |
| 747 |
PARALYSIS |
12 |
0.0008 |
| 748 |
CEREBRAL HAEMORRHAGE |
30 |
0.0008 |
| 749 |
NIGHT SWEATS |
27 |
0.0008 |
| 750 |
MENINGIOMA |
13 |
0.0008 |
| 751 |
HEPATIC CANCER |
20 |
0.0008 |
| 752 |
LOCALISED INFECTION |
20 |
0.0008 |
| 753 |
CONSTIPATION |
180 |
0.0008 |
| 754 |
PRODUCT USE ISSUE |
155 |
0.0008 |
| 755 |
CHEST PAIN |
151 |
0.0008 |
| 756 |
DYSPHAGIA |
77 |
0.0008 |
| 757 |
HAIR COLOUR CHANGES |
10 |
0.0008 |
| 758 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
23 |
0.0008 |
| 759 |
CYTOKINE RELEASE SYNDROME |
16 |
0.0008 |
| 760 |
INFLAMMATION |
41 |
0.0008 |
| 761 |
MANIA |
13 |
0.0008 |
| 762 |
PHOTOSENSITIVITY REACTION |
13 |
0.0008 |
| 763 |
BREAST CANCER FEMALE |
21 |
0.0008 |
| 764 |
DRUG PRESCRIBING ERROR |
15 |
0.0008 |
| 765 |
DRUG INEFFECTIVE |
1021 |
0.0008 |
| 766 |
TOOTHACHE |
14 |
0.0008 |
| 767 |
BLISTER |
43 |
0.0008 |
| 768 |
DIVERTICULITIS |
21 |
0.0008 |
| 769 |
RENAL CANCER |
36 |
0.0008 |
| 770 |
WHITE BLOOD CELL COUNT DECREASED |
81 |
0.0007 |
| 771 |
CONDITION AGGRAVATED |
224 |
0.0007 |
| 772 |
DIPLOPIA |
19 |
0.0007 |
| 773 |
POST PROCEDURAL COMPLICATION |
14 |
0.0007 |
| 774 |
PULMONARY HYPERTENSION |
15 |
0.0007 |
| 775 |
WOUND |
20 |
0.0007 |
| 776 |
MASS |
10 |
0.0007 |
| 777 |
PERIPHERAL SWELLING |
110 |
0.0007 |
| 778 |
COMA |
34 |
0.0007 |
| 779 |
TYPE 2 DIABETES MELLITUS |
24 |
0.0007 |
| 780 |
LYMPHOMA |
11 |
0.0007 |
| 781 |
BLOOD PRESSURE FLUCTUATION |
17 |
0.0007 |
| 782 |
DELUSION |
11 |
0.0007 |
| 783 |
HEPATOCELLULAR INJURY |
10 |
0.0007 |
| 784 |
RASH PRURITIC |
38 |
0.0007 |
| 785 |
OSTEONECROSIS |
23 |
0.0007 |
| 786 |
LIVER INJURY |
17 |
0.0007 |
| 787 |
BODY TEMPERATURE INCREASED |
14 |
0.0007 |
| 788 |
URINARY INCONTINENCE |
20 |
0.0007 |
| 789 |
STEVENS-JOHNSON SYNDROME |
15 |
0.0007 |
| 790 |
COLON CANCER |
10 |
0.0007 |
| 791 |
CARDIOVASCULAR DISORDER |
17 |
0.0007 |
| 792 |
HAEMORRHOIDS |
13 |
0.0007 |
| 793 |
FREQUENT BOWEL MOVEMENTS |
18 |
0.0007 |
| 794 |
LOWER RESPIRATORY TRACT INFECTION |
30 |
0.0007 |
| 795 |
DYSGEUSIA |
49 |
0.0007 |
| 796 |
OXYGEN SATURATION DECREASED |
37 |
0.0007 |
| 797 |
OSTEOPOROSIS |
27 |
0.0007 |
| 798 |
PERICARDITIS |
11 |
0.0007 |
| 799 |
LIVER FUNCTION TEST INCREASED |
14 |
0.0007 |
| 800 |
INTENTIONAL PRODUCT USE ISSUE |
57 |
0.0007 |
| 801 |
PROCEDURAL PAIN |
18 |
0.0006 |
| 802 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
19 |
0.0006 |
| 803 |
LACTIC ACIDOSIS |
21 |
0.0006 |
| 804 |
BLOOD URINE PRESENT |
12 |
0.0006 |
| 805 |
RIB FRACTURE |
13 |
0.0006 |
| 806 |
APHASIA |
19 |
0.0006 |
| 807 |
WHITE BLOOD CELL COUNT INCREASED |
24 |
0.0006 |
| 808 |
OROPHARYNGEAL PAIN |
57 |
0.0006 |
| 809 |
SWELLING FACE |
40 |
0.0006 |
| 810 |
RASH ERYTHEMATOUS |
29 |
0.0006 |
| 811 |
CARDIAC ARREST |
50 |
0.0006 |
| 812 |
HAEMORRHAGE |
63 |
0.0006 |
| 813 |
FAECES DISCOLOURED |
13 |
0.0006 |
| 814 |
URINARY RETENTION |
20 |
0.0006 |
| 815 |
GAIT INABILITY |
20 |
0.0006 |
| 816 |
ABDOMINAL PAIN LOWER |
15 |
0.0006 |
| 817 |
ARRHYTHMIA |
28 |
0.0006 |
| 818 |
BLOOD PRESSURE DECREASED |
39 |
0.0006 |
| 819 |
HOT FLUSH |
44 |
0.0006 |
| 820 |
BLOOD GLUCOSE INCREASED |
110 |
0.0006 |
| 821 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
15 |
0.0006 |
| 822 |
DISORIENTATION |
23 |
0.0006 |
| 823 |
ADVERSE DRUG REACTION |
52 |
0.0006 |
| 824 |
TACHYCARDIA |
51 |
0.0006 |
| 825 |
CARDIAC FAILURE CONGESTIVE |
46 |
0.0006 |
| 826 |
ERUCTATION |
11 |
0.0006 |
| 827 |
PRESCRIBED OVERDOSE |
11 |
0.0006 |
| 828 |
PLASMA CELL MYELOMA |
22 |
0.0006 |
| 829 |
EAR INFECTION |
15 |
0.0006 |
| 830 |
RETCHING |
12 |
0.0006 |
| 831 |
NASAL CONGESTION |
33 |
0.0006 |
| 832 |
GALLBLADDER DISORDER |
10 |
0.0006 |
| 833 |
RECTAL HAEMORRHAGE |
24 |
0.0006 |
| 834 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
14 |
0.0006 |
| 835 |
ATRIAL FIBRILLATION |
54 |
0.0006 |
| 836 |
NERVOUS SYSTEM DISORDER |
17 |
0.0005 |
| 837 |
LABORATORY TEST ABNORMAL |
16 |
0.0005 |
| 838 |
SYNCOPE |
54 |
0.0005 |
| 839 |
RENAL INJURY |
16 |
0.0005 |
| 840 |
ALOPECIA |
103 |
0.0005 |
| 841 |
DRY SKIN |
70 |
0.0005 |
| 842 |
ILLNESS |
54 |
0.0005 |
| 843 |
SWELLING |
49 |
0.0005 |
| 844 |
AGEUSIA |
13 |
0.0005 |
| 845 |
HERNIA |
10 |
0.0005 |
| 846 |
ECZEMA |
27 |
0.0005 |
| 847 |
PALLOR |
14 |
0.0005 |
| 848 |
FLUID RETENTION |
26 |
0.0005 |
| 849 |
LIP SWELLING |
17 |
0.0005 |
| 850 |
KIDNEY INFECTION |
10 |
0.0005 |
| 851 |
GASTROOESOPHAGEAL REFLUX DISEASE |
41 |
0.0005 |
| 852 |
PRURITUS GENERALISED |
11 |
0.0005 |
| 853 |
ALTERED STATE OF CONSCIOUSNESS |
11 |
0.0005 |
| 854 |
ERYTHEMA |
104 |
0.0005 |
| 855 |
CARDIO-RESPIRATORY ARREST |
21 |
0.0005 |
| 856 |
ABDOMINAL DISCOMFORT |
84 |
0.0005 |
| 857 |
LACRIMATION INCREASED |
15 |
0.0005 |
| 858 |
ARTHRALGIA |
206 |
0.0005 |
| 859 |
MYALGIA |
84 |
0.0005 |
| 860 |
PRURITUS |
189 |
0.0005 |
| 861 |
TREMOR |
81 |
0.0005 |
| 862 |
CONFUSIONAL STATE |
78 |
0.0005 |
| 863 |
NEEDLE ISSUE |
14 |
0.0005 |
| 864 |
DRY EYE |
24 |
0.0005 |
| 865 |
VERTIGO |
29 |
0.0005 |
| 866 |
DYSKINESIA |
19 |
0.0005 |
| 867 |
ADVERSE EVENT |
43 |
0.0005 |
| 868 |
GASTRIC DISORDER |
16 |
0.0005 |
| 869 |
NECK PAIN |
26 |
0.0005 |
| 870 |
MALAISE |
204 |
0.0005 |
| 871 |
HEART RATE INCREASED |
46 |
0.0005 |
| 872 |
RHINORRHOEA |
30 |
0.0005 |
| 873 |
LUNG NEOPLASM MALIGNANT |
19 |
0.0005 |
| 874 |
BLOOD GLUCOSE DECREASED |
22 |
0.0005 |
| 875 |
SPEECH DISORDER |
24 |
0.0005 |
| 876 |
PAIN |
281 |
0.0005 |
| 877 |
INTERNATIONAL NORMALISED RATIO INCREASED |
13 |
0.0005 |
| 878 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
18 |
0.0005 |
| 879 |
NEURALGIA |
11 |
0.0005 |
| 880 |
PRODUCT SUBSTITUTION ISSUE |
26 |
0.0005 |
| 881 |
MUSCULAR WEAKNESS |
51 |
0.0004 |
| 882 |
INFLUENZA |
50 |
0.0004 |
| 883 |
AGGRESSION |
22 |
0.0004 |
| 884 |
BRONCHITIS |
32 |
0.0004 |
| 885 |
MYOCARDIAL INFARCTION |
75 |
0.0004 |
| 886 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
77 |
0.0004 |
| 887 |
HEART RATE DECREASED |
15 |
0.0004 |
| 888 |
VISUAL ACUITY REDUCED |
14 |
0.0004 |
| 889 |
INTENTIONAL DOSE OMISSION |
12 |
0.0004 |
| 890 |
ANGINA PECTORIS |
12 |
0.0004 |
| 891 |
HYPERSOMNIA |
12 |
0.0004 |
| 892 |
FOETAL EXPOSURE DURING PREGNANCY |
34 |
0.0004 |
| 893 |
DYSPEPSIA |
41 |
0.0004 |
| 894 |
GAIT DISTURBANCE |
78 |
0.0004 |
| 895 |
PSYCHOTIC DISORDER |
12 |
0.0004 |
| 896 |
LIMB INJURY |
11 |
0.0004 |
| 897 |
PAIN IN EXTREMITY |
119 |
0.0004 |
| 898 |
EXPOSURE DURING PREGNANCY |
25 |
0.0004 |
| 899 |
TREATMENT NONCOMPLIANCE |
22 |
0.0004 |
| 900 |
OCULAR HYPERAEMIA |
19 |
0.0004 |
| 901 |
HEADACHE |
250 |
0.0004 |
| 902 |
FLUSHING |
40 |
0.0004 |
| 903 |
CHEST DISCOMFORT |
40 |
0.0004 |
| 904 |
PRODUCT DOSE OMISSION IN ERROR |
11 |
0.0004 |
| 905 |
SWOLLEN TONGUE |
12 |
0.0004 |
| 906 |
ACCIDENTAL OVERDOSE |
14 |
0.0004 |
| 907 |
AGITATION |
28 |
0.0004 |
| 908 |
MOOD SWINGS |
12 |
0.0004 |
| 909 |
MOVEMENT DISORDER |
12 |
0.0004 |
| 910 |
NEPHROLITHIASIS |
17 |
0.0004 |
| 911 |
MATERNAL EXPOSURE DURING PREGNANCY |
33 |
0.0004 |
| 912 |
LOSS OF CONSCIOUSNESS |
47 |
0.0004 |
| 913 |
FALL |
122 |
0.0004 |
| 914 |
BRADYCARDIA |
19 |
0.0004 |
| 915 |
SKIN EXFOLIATION |
30 |
0.0004 |
| 916 |
LIMB DISCOMFORT |
11 |
0.0004 |
| 917 |
SLEEP DISORDER |
25 |
0.0004 |
| 918 |
ABNORMAL BEHAVIOUR |
14 |
0.0004 |
| 919 |
CARDIAC DISORDER |
33 |
0.0004 |
| 920 |
SINUSITIS |
36 |
0.0004 |
| 921 |
HYPOACUSIS |
15 |
0.0003 |
| 922 |
MOBILITY DECREASED |
25 |
0.0003 |
| 923 |
HEAD INJURY |
11 |
0.0003 |
| 924 |
CATARACT |
20 |
0.0003 |
| 925 |
IRRITABILITY |
20 |
0.0003 |
| 926 |
DRUG EFFECT INCOMPLETE |
12 |
0.0003 |
| 927 |
HAEMATOCHEZIA |
18 |
0.0003 |
| 928 |
HYPERSENSITIVITY |
60 |
0.0003 |
| 929 |
WEIGHT INCREASED |
72 |
0.0003 |
| 930 |
WHEEZING |
19 |
0.0003 |
| 931 |
BLINDNESS |
13 |
0.0003 |
| 932 |
DYSARTHRIA |
12 |
0.0003 |
| 933 |
CEREBROVASCULAR ACCIDENT |
53 |
0.0003 |
| 934 |
HIP FRACTURE |
10 |
0.0003 |
| 935 |
SKIN DISCOLOURATION |
14 |
0.0003 |
| 936 |
DEPRESSION |
69 |
0.0003 |
| 937 |
DIZZINESS |
149 |
0.0003 |
| 938 |
EYE SWELLING |
11 |
0.0003 |
| 939 |
INSOMNIA |
78 |
0.0003 |
| 940 |
COLITIS ULCERATIVE |
13 |
0.0003 |
| 941 |
VISUAL IMPAIRMENT |
36 |
0.0003 |
| 942 |
SURGERY |
17 |
0.0003 |
| 943 |
JOINT SWELLING |
35 |
0.0003 |
| 944 |
POLLAKIURIA |
12 |
0.0003 |
| 945 |
PRODUCT DOSE OMISSION ISSUE |
83 |
0.0003 |
| 946 |
CONVULSION |
16 |
0.0003 |
| 947 |
DISCOMFORT |
17 |
0.0003 |
| 948 |
ANAPHYLACTIC REACTION |
15 |
0.0003 |
| 949 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
13 |
0.0003 |
| 950 |
INFLUENZA LIKE ILLNESS |
22 |
0.0003 |
| 951 |
PARAESTHESIA |
42 |
0.0003 |
| 952 |
PALPITATIONS |
31 |
0.0003 |
| 953 |
SOMNOLENCE |
53 |
0.0003 |
| 954 |
CONTUSION |
25 |
0.0003 |
| 955 |
ASTHMA |
29 |
0.0003 |
| 956 |
MENTAL DISORDER |
11 |
0.0003 |
| 957 |
HYPERHIDROSIS |
32 |
0.0002 |
| 958 |
NASOPHARYNGITIS |
45 |
0.0002 |
| 959 |
MUSCLE SPASMS |
43 |
0.0002 |
| 960 |
HYPOAESTHESIA |
35 |
0.0002 |
| 961 |
COLORECTAL CANCER |
11 |
0.0002 |
| 962 |
BURNING SENSATION |
16 |
0.0002 |
| 963 |
BALANCE DISORDER |
19 |
0.0002 |
| 964 |
OVERDOSE |
47 |
0.0002 |
| 965 |
AMNESIA |
14 |
0.0002 |
| 966 |
DEPRESSED MOOD |
11 |
0.0002 |
| 967 |
VISION BLURRED |
28 |
0.0002 |
| 968 |
PROSTATE CANCER |
16 |
0.0002 |
| 969 |
ILL-DEFINED DISORDER |
12 |
0.0002 |
| 970 |
EYE PAIN |
11 |
0.0002 |
| 971 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
10 |
0.0002 |
| 972 |
NERVOUSNESS |
10 |
0.0002 |
| 973 |
ANXIETY |
54 |
0.0002 |
| 974 |
INTENTIONAL PRODUCT MISUSE |
16 |
0.0002 |
| 975 |
MUSCULOSKELETAL STIFFNESS |
16 |
0.0002 |
| 976 |
NO ADVERSE EVENT |
33 |
0.0002 |
| 977 |
FEELING HOT |
11 |
0.0002 |
| 978 |
FEELING ABNORMAL |
41 |
0.0002 |
| 979 |
MIGRAINE |
16 |
0.0002 |
| 980 |
INFUSION RELATED REACTION |
11 |
0.0002 |
| 981 |
ARTHRITIS |
13 |
0.0002 |
| 982 |
HALLUCINATION |
12 |
0.0002 |
| 983 |
INJURY |
11 |
0.0002 |
| 984 |
MEMORY IMPAIRMENT |
21 |
0.0002 |
| 985 |
UNEVALUABLE EVENT |
11 |
0.0001 |
| 986 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
29 |
0.0001 |
| 987 |
INCORRECT DOSE ADMINISTERED |
32 |
0.0001 |
| 988 |
URTICARIA |
22 |
0.0001 |
| 989 |
PSORIASIS |
12 |
0.0001 |
| 990 |
DRUG DEPENDENCE |
14 |
0.0001 |
| 991 |
INJECTION SITE PAIN |
21 |
0.0001 |